Phenotypic Detection Methods, Clinical Outcomes, and Therapeutic Strategies for OXA-Type Carbapenemase-Producing

Pranay R Ullengala1, Ravindra V Shinde1, Satish R Patil1

  • 1Department of Microbiology, Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth (Deemed to be University), Karad, IND.

Cureus
|June 29, 2026
PubMed

Insights

Multidrug-resistant Acinetobacter baumannii, a major cause of hospital infections, is often resistant to carbapenems due to OXA-type beta-lactamases. New therapies are crucial for managing these severe infections.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Acinetobacter species are significant nosocomial pathogens, particularly Acinetobacter baumannii.
  • These bacteria cause severe infections like ventilator-associated pneumonia and bloodstream infections with high mortality rates.
  • Rapid development of multidrug resistance (MDR) complicates treatment in tertiary care settings.

Purpose of the Study:

  • To review the pathophysiology, virulence, clinical symptoms, and epidemiology of MDR Acinetobacter species.
  • To discuss laboratory challenges and methodologies for isolating and profiling resistant strains.
  • To evaluate clinical outcomes and therapeutic strategies for OXA-driven carbapenem resistance in India.

Main Methods:

  • Literature review focusing on OXA-type carbapenem-hydrolyzing class D beta-lactamases (CHDLs) and extended-spectrum beta-lactamases (ESBLs).
  • Analysis of laboratory diagnostic methods for isolation and characterization of resistant Acinetobacter.
  • Evaluation of clinical data and treatment outcomes from Indian intensive care units.

Main Results:

  • OXA-type CHDLs are a primary mechanism for beta-lactam resistance in Acinetobacter.
  • Specific laboratory techniques are essential for accurate identification of these resistant pathogens.
  • High prevalence of these resistant strains in Indian ICUs is associated with severe clinical outcomes.

Conclusions:

  • Effective management of MDR Acinetobacter requires understanding resistance mechanisms and clinical impact.
  • Tailored combination therapies and novel treatments like sulbactam-durlobactam show promise.
  • Urgent need for improved therapeutic strategies to combat severe OXA-driven infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...